Streetbeat News

Earnings

WBS

Webster Financial Corporation (NYSE:WBS) reported Q4 earnings per share of $1.46, meeting market estimates, but fell short on sales with $571.02 million against expectations of $602.807 million. Despite the sales miss, the company highlighted strong financial performance and strategic accomplishments, including the acquisition of Ametros Financial. Shares dropped 2.3% after the report. Analysts from Raymond James and JP Morgan raised their price targets for WBS, with Raymond James maintaining an Outperform rating and JP Morgan upgrading the stock from Neutral to Overweight.

Portfolio Pulse from Avi Kapoor

January 24, 2024 | 12:05 pm

SF

Stifel Financial (NYSE:SF) reported Q4 adjusted EPS of $1.50, surpassing the $1.31 estimate by 14.5%, despite a 5.06% decrease from last year's $1.58 EPS. Sales reached $1.15B, exceeding the $1.07B estimate by 7.10% and marking a 2.14% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:03 pm

FBP

First BanCorp (NYSE:FBP) reported Q4 adjusted EPS of $0.49, surpassing the $0.36 estimate, marking a 22.5% increase from the previous year. However, sales of $196.68M fell short of the $206.11M estimate, a 4.32% decrease from the prior year.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:03 pm

GD

General Dynamics reported a record year-end backlog of $93.6 billion, the highest in the company's history, indicating strong future revenues and potential growth.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:03 pm

USAP

Universal Stainless is expected to report Q4 sales between $78M-$80M and FY23 sales between $284M-$286M.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:02 pm

KMB

Kimberly-Clark Corporation reported Q4 adjusted earnings per share (EPS) of $1.51, missing the consensus estimate of $1.54 by 1.95%. The company's quarterly sales were $4.97 billion, slightly below the expected $4.98 billion, marking a 0.20% miss. However, sales saw a marginal increase of 0.12% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:01 pm

TDY

Teledyne Technologies provided its Q1 2024 earnings outlook, projecting GAAP EPS of $3.73 to $3.86 and non-GAAP EPS of $4.55 to $4.65, surpassing the $3.95 estimate. Full year 2024 GAAP EPS is expected to be $17.15 to $17.53, and non-GAAP EPS is forecasted to be $20.35 to $20.68. The non-GAAP figures exclude amortization of acquired intangible assets, FLIR integration costs, and acquisition-related tax matters. The anticipated tax rate for 2024 is 22.5%, excluding discrete items.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:01 pm

GD

General Dynamics (NYSE:GD) reported Q4 2023 earnings per share (EPS) of $3.64, missing the consensus estimate of $3.71 by 1.89%. However, the company's quarterly sales of $11.70 billion exceeded expectations of $11.37 billion by 2.88% and marked a 7.82% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:01 pm

DD

DuPont forecasts Q1 FY2024 net sales of around $2.8 billion and adjusted EPS of $0.63-$0.65, falling short of the consensus estimates of $0.87 EPS and $3.04 billion in sales.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:01 pm

ACAD

ACADIA Pharmaceuticals (NASDAQ:ACAD) has received 12 analyst ratings in the last three months, with an average 12-month price target of $34.58, up from the previous $30.29. Ratings range from bullish to indifferent, with recent actions including upgrades and initiations of coverage. The company's financial performance shows strong revenue growth and net margin, but challenges in ROA. ACADIA focuses on CNS disorder treatments and seeks to in-license or acquire complementary products.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 12:00 pm